Dipentum (MEDA Pharmaceuticals)
Welcome to the PulseAid listing for the Dipentum drug offered from MEDA Pharmaceuticals. This Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | MEDA Pharmaceuticals |
NON-PROPRIETARY NAME: | olsalazine sodium |
SUBSTANCE NAME: | OLSALAZINE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, GELATIN COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-05-15 |
END MARKETING DATE: | 0000-00-00 |
Dipentum HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipentum from MEDA Pharmaceuticals |
LABELER NAME: | MEDA Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2015-05-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0037-6860_43f6c437-5c6a-4171-893a-c5669a8fa082 |
PRODUCT NDC: | 0037-6860 |
APPLICATION NUMBER: | NDA019715 |
Other OLSALAZINE SODIUM Pharmaceutical Manufacturers / Labelers: